Shares of Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) were up 5.9% during trading on Thursday. The stock traded as high as $43.76 and last traded at $43.76. 250 shares changed hands during trading, a decline of 81% from the average daily volume of 1,320 shares. The stock had previously closed at $41.31.
Hikma Pharmaceuticals Stock Performance
The stock’s 50 day simple moving average is $43.27 and its two-hundred day simple moving average is $39.77.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures and markets a broad range of medicines. Founded in Jordan in 1978 by Samih Darwazah, the company has grown from a regional business into an international healthcare group serving patients and healthcare providers in markets across North America, Europe and the Middle East and North Africa.
Hikma operates through three principal businesses: Injectables, Generics and Branded Medicines. Its products include injectable medicines used in hospitals and other clinical settings, generic prescription medicines, and branded and licensed pharmaceutical products for a range of therapeutic areas.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
